Antiphospholipid Antibodies Linked to Future CV Events
The study raises the possibility of one day treating the immune system in some individuals for the prevention and treatment of cardiovascular disease, researchers suggest.
Medscape Medical News
source https://www.medscape.com/viewarticle/990513?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/990513?src=rss
Comments
Post a Comment